Health Sciences Assistant Clinical Professor
Skaggs School of Pharmacy and Pharmaceutical Sciences
Prior to joining the faculty at SSPPS in September 2018, Dr. Hart completed a PGY2 Residency and Fellowship in Geriatric Pharmacotherapy and served as an instructor in the PharmD program at the University of Washington School of Pharmacy. Her research aims to optimize medication use in older adults, particularly using pharmacoepidemiologic methods to examine risks and patterns of medication use in older adults. Her research to date has specifically focused in the areas of central nervous system-active medications, falls, and dementia. She is also interested in the implementation and evaluation of innovative pharmacy practice models in the care of older adults. In addition, she has an interest in the scholarship of teaching and learning. Further, she is passionate about justice, equity, diversity, and inclusion, with a focus on the LGBTQIA+ community. Dr. Hart is a Board Certified Pharmacotherapy Specialist (BCPS) and Board Certified Geriatric Pharmacist (BCGP).
Education: Bachelor of Science, Individualized Studies (Public Health), University of Washington (2010); Doctor of Pharmacy, University of Washington (2014); Master of Science in Pharmaceutical Outcomes Research and Policy, University of Washington (2017); PGY1 Pharmacy Practice Residency, U.S. Department of Veterans Affairs (VA) Puget Sound Health Care System (2015); PGY2 Residency in Geriatric Pharmacotherapy, University of Washington School of Pharmacy (2016); Fellowship in Geriatric Pharmacotherapy, University of Washington School of Pharmacy (2018); Board Certification in Pharmacotherapy (2016); Board Certification in Geriatric Pharmacy (2017)
Awards and Honors: Next Gen-Rx Award, American Society of Consultant Pharmacists (2022); Fellow of the American Society of Consultant Pharmacists (2022); Distinguished Alumni Award: Early Career Achievement Award, University of Washington School of Pharmacy (2022); Alumni Legends Award, University of Washington School of Pharmacy (2020); National Center of Leadership in Academic Medicine (2020); Alumni Award/Alumni Honor Roll, Rho Chi Academic Honor Society (2018); Junior Investigator Award, American College of Clinical Pharmacy Research Institute Futures Grants (2016); University of Washington Retirement Association Fellowship in Aging (2016); Dean’s Club Humanitarian Award, University of Washington School of Pharmacy (2014); Faculty Excellence Award, University of Washington School of Pharmacy (2014); Phi Lambda Sigma Pharmacy Leadership Society (2012); Rho Chi Academic Honor Society (2012)
Leadership Experience: Faculty Director for Student Affairs, SSPPS; Co-Chair of Alumni Relations Committee, SSPPS; Co-Lead of Medication Safety and Transitions of Care Committee, American Society of Consultant Pharmacists (ASCP); Mentorship Officer, RxSHARE (Pharmacists for Sexual and Gender Health Advocacy, Reform, and Equity); SSPPS Alternate Faculty Delegate, American Association of Colleges of Pharmacy (AACP); Medication Education Team Co-Lead, San Diego/Imperial Geriatric Education Center Geriatrics Workforce Enhancement Program (GWEP); Pharmacy Educators and Research Council, ASCP; Faculty Advisor, SSPPS CAPSLead; Faculty Advisor, SSPPS ASCP Student Chapter; Faculty Advisor, SSPPS Phi Lambda Sigma Epsilon Alpha Chapter; Faculty Advisor, UC San Diego Pre-Pharmacy Society; Grand Council Deputy (Advisor), SSPPS Kappa Psi Pharmaceutical Fraternity, Inc. Delta Phi Chapter.
- Co-Chair and Lecturer for Pharmacy Practice I (SPPS 201)
- Co-Chair and Lecturer for Drug Information in Study Design and Biostatistics I (SPPS 206)
- Chair and Lecturer for Geriatric Pharmacotherapy (SPPS 265)
- Lecturer for Therapeutics III (SPPS 212C)
- Lecturer for Pharmacy Practice III (SPPS 203)
- Lecturer for Applied Pharmacoeconomics (SPPS 209)
- Lecturer for Advanced Professional Practice I (SPPS 213A)
- Evaluating risks associated with medication use in older adults
- Evaluating prescribing/medication use patterns in older adults
- Enhancing safe and effective medication use in older adults
- Justice, equity, diversity, and inclusion efforts with a focus on the LGBTQIA+ community
- Nguyen K, et al. (2022). Polypharmacy in the emergency department. Clin Geriatr Med. 38(4):727-732.
- Luli AJ, et al. (2022). A systematic approach to providing COVID-19 vaccinations in the community by student pharmacists. Pharmacy (Basel). 10(4):93.
- Hart LA, et al. (2022). Change in central nervous system-active medication use following fall-related injury in older adults. J Am Geriatr Soc. 70(1):168-177.
- Lin SY, et al. (2021). Evaluation of pharmaceutical pictograms by older "turkers": A cross-sectional crowdsourced study. Res Social Adm Pharm. 17(6):1079-1090.
- Hart LA, et al. (2020) Use of fall risk-increasing drugs around a fall-related injury in older adults: a systematic review. J Am Geriatr Soc. 68(6):1334-1343.
- Kaufmann CN, et al. (2020) Association between the use of non-benzodiazepine hypnotics and cognitive outcomes: a systematic review. Curr Sleep Med Rep. 6(1):11-20.
- Hart LA, et al. (2019) The association between central nervous system-active medication use and fall-related injury in community-dwelling older adults with dementia. Pharmacotherapy. 39(5):530-543.
- Marcum ZA, et al. (2019) Self-reported barriers to medication use in older women: Findings from the Women's Health Initiative. J Am Pharm Assoc. 59(6);842-847.
- Hart LA, et al. (2018) Methods of estimating kidney function for drug dosing in special populations. Clin Pharmacokinet. 57(8):943-976.
- Gray SL, et al. (2017) Meta-analysis of interventions to reduce adverse drug reactions in older adults. J Am Geriatr Soc. 66(2):282-288.